BMY
Bristol-Myers Squibb CompanyWhen BMY passed all Ten ChecksBristol-Myers Squibb Company
history · not a forecastOver the past 10 years, BMY has passed all Ten Checks on 19 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +11.6% in Jan 2026, peaked day 8.
- Mar 2026+1.8% -4.1%
- Jan 2026+11.6% -2.3%
- Nov 2025+11.5% -1.6%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about BMY’s checks
How many technical checks does BMY pass right now?
As of the Aug 27, 2026 close, BMY passes 8 of 10 fixed technical checks — the checks not passing: pulled back to support, outperforming the market.
Why does BMY fail the "outperforming the market" check?
BMY has trailed the S&P 500 by 0.7 percentage points over the last 20 sessions, so the relative-strength check fails. It passes once BMY leads the index again.
What price would change BMY's check count?
The nearest flip level is "adequate stop room" fails on a close below $66.63. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.